Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia
Chavez, Julio C., MD, Piris-Villaespesa, Miguel, MD, Dalia, Samir, MD, Powers, John, PhD, Turba, Elyce, RN, Nodzon, Lisa, ARNP, Komrokji, Rami, MD, Sokol, Lubomir, PhD, Locke, Frederick L., MD, Lancet, Jeffrey, MD, Sotomayor, Eduardo M., MD, Kharfan-Dabaja, Mohamed A., MD, Pinilla-Ibarz, Javier, MD, PhD
Published in Leukemia research (01.08.2016)
Published in Leukemia research (01.08.2016)
Get full text
Journal Article
A Single-Arm, Open-Label Phase 2 Pilot Study of Vyxeos (CPX-351) in Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia
Shah, Bijal D., Rozario, Nicole, Turba, Elyce P., Bello, Celeste, Chavez, Julio C., Sokol, Lubomir, Brayer, Jason, Lancet, Jeffrey E.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis
Komrokji, Rami S., Seymour, John F., Roberts, Andrew W., Wadleigh, Martha, To, L. Bik, Scherber, Robyn, Turba, Elyce, Dorr, Andrew, Zhu, Joy, Wang, Lixia, Granston, Tanya, Campbell, Mary S., Mesa, Ruben A.
Published in Blood (23.04.2015)
Published in Blood (23.04.2015)
Get full text
Journal Article
Durable Complete Response to AMG 655 (Conatumumab) and Vorinostat in a Patient With Relapsed Classical Hodgkin Lymphoma: Extraordinary Response from a Phase 1b Clinical Protocol
Skelton, William Paul, Turba, Elyce, Sokol, Lubomir
Published in Clinical lymphoma, myeloma and leukemia (01.12.2020)
Published in Clinical lymphoma, myeloma and leukemia (01.12.2020)
Get full text
Journal Article
A Phase II Trial of Ibrutinib and PD-1 Blockade in Asymptomatic High Risk Chronic Lymphocytic Leukemia to Improve Immune Function
Chavez, Julio C., Grajales-Cruz, Ariel F, Volpe, Virginia Olivia, Turba, Elyce P., Nodzon, Lisa, Sahakian, Eva, Rozario, Nicole, Pinilla Ibarz, Javier
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Retrospective, Single-Institution Analysis Based on Risk Features and Debulking Strategy with Anti-CD20 Monoclonal Antibody
Grajales-Cruz, Ariel F, Chavez, Julio, Volpe, Virginia Olivia, Sandoval-Sus, Jose, Shah, Bijal, Bello, Celeste, Sokol, Lubomir, Fisher, Shanel, Nair, Rajesh R, Seongseok, Yun, Saeed, Hayder, Isenalumhe, Leidy, Turba, Elyce P., Nodzon, Lisa, Pinilla Ibarz, Javier
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis
Chavez, Julio C, Grajales, Ariel, Sandoval-Sus, Jose, Turba, Elyce, Nodzon, Lisa, Uriepero-Palma, Angimar, Ammad-Ud-Din, Mohammad, Sahakian, Eva, Komrokji, Rami, Sokol, Lubomir, Locke, Frederick L, Shah, Bijal, Lancet, Jeffrey, Sotomayor, Eduardo M, Kharfan-Dabaja, Mohamed A., Bello, Celeste, Pinilla-Ibarz, Javier
Published in Clinical lymphoma, myeloma and leukemia (01.06.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.06.2024)
Get full text
Journal Article
Long-Term Follow up of Front-Line Therapy with Ofatumumab, High Dose Methylprednisolone and Lenalidomide (HiLO trial) for Treatment-Naïve Chronic Lymphocytic Leukemia
Grajales-Cruz, Ariel Felipe, Chavez, Julio C., Turba, Elyce P., Nodzon, Lisa, Perez Leal, Francisco, Sandoval-Sus, Jose, Komrokji, Rami S., Locke, Frederick L., Kharfan-Dabaja, Mohamed A, Shah, Bijal D., Sokol, Lubomir, Bello, Celeste M., Pinilla Ibarz, Javier
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Nurses in clinical trials: perceptions of impact on the research enterprise
Jones, Carolynn T, Griffith, Catherine A, Fisher, Cheryl A, Grinke, Kathleen A, Keller, Rosemary, Lee, Hyacinth, Purdom, Michelle, Turba, Elyce
Published in Journal of research in nursing (01.03.2022)
Published in Journal of research in nursing (01.03.2022)
Get full text
Journal Article
Brentuximab vedotin plus doxorubicin and dacarbazine in nonbulky limited-stage classical Hodgkin lymphoma
Abramson, Jeremy S., Bengston, Elizabeth, Redd, Robert, Barnes, Jeffrey A., Takvorian, Tak, Sokol, Lubomir, Lansigan, Frederick, Armand, Philippe, Shah, Bijal, Jacobsen, Eric, Martignetti, Rosalba, Turba, Elyce, Metzler, Sara, Patterson, Victoria, LaCasce, Ann S., Bello, Celeste M.
Published in Blood advances (11.04.2023)
Published in Blood advances (11.04.2023)
Get full text
Journal Article
Sequential Therapy with Ofatumumab, High Dose Methylprednisolone and Lenalidomide Is a Safe and Effective Regimen for the Treatment of Previously Treated and Untreated CLL/SLL: The Hilo Trial
Pinilla-Ibarz, Javier, Chavez, Julio C, Turba, Elyce, Nodzon, Lisa, rock-Klotz, Jennifer, Dalia, Samir, Komrokji, Rami S., Locke, Frederick L., Kharfan-Dabaja, Mohamed A, Bello, Celeste M.
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Sézary Syndrome: Clinicopathological and Immunophenotypical Characteristics and Outcomes
Roe, Christa, Rock-Klotz, Jennifer, Turba, Elyce, Salamanca, Christopher Rodriguez, Bennett, Janice, Farquharson, Farrah, Bastien, Sem, Williams, Barbara, Levy, Rebecca, Li, Yibo, Montejo, Michael, Ayala, Ernesto, Horna, Pedro, Glass, Lewis F, Komrokji, Rami S., Sokol, Lubomir
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
A retrospective pilot study comparing data from monitoring reports to identify staffing influence on protocol deviation rates
Jones, Carolynn, Fisher, Cheryl, Griffith, Catherine A., Bailey, Joy, Barlow, Candida, Cusack, Georgie, Grinke, Kathleen, Hall, Kathryn E., Keller, Rosemary, Turba, Elyce, Jester, Penelope
Published in International Journal of Clinical Trials (23.01.2018)
Published in International Journal of Clinical Trials (23.01.2018)
Get full text
Journal Article
Durable Complete Response to AMG 655 (Conatumumab) and Vorinostat in a Patient With Relapsed Classical Hodgkin Lymphoma: Extraordinary Response from a Phase 1b Clinical Protocol
Skelton, William Paul, Turba, Elyce, Sokol, Lubomir
Published in Clinical lymphoma, myeloma & leukemia (01.12.2020)
Published in Clinical lymphoma, myeloma & leukemia (01.12.2020)
Get full text
Report